"EPSTATE SR 150: Effective Relief for Diabetic Neuropathy"

May 25, 2024

EPSTATE SR 150 

Epalrestat Tablets ER (50mg)

Introduction

Epalrestat Tablets ER (50mg), marketed under the brand name EPSTATE SR 150, is a medication primarily used for the management of diabetic neuropathy. Diabetic neuropathy is a type of nerve damage that can occur in people with diabetes, and Epalrestat helps to alleviate its symptoms by inhibiting the enzyme aldose reductase.

Uses

  • Diabetic Neuropathy Management: EPSTATE SR 150 is specifically used to treat diabetic neuropathy by reducing nerve pain, numbness, and other related symptoms.
  • Enzyme Inhibition: Epalrestat works by inhibiting aldose reductase, an enzyme involved in the accumulation of sorbitol in nerve cells, which is a contributing factor to nerve damage in diabetic patients.

Dosage

  • Standard Dosage: The typical dosage of EPSTATE SR 150 is 50mg taken three times daily. The exact dosage may vary depending on the patient's condition and response to the medication.
  • Administration: It is usually taken orally, with or without food. Consistent timing in taking the medication each day is crucial for maintaining stable drug levels in the body.
  • Monitoring: Regular monitoring by a healthcare provider is essential to ensure the medication’s effectiveness and to make any necessary adjustments to the dosage.

Side Effects

  • Common Side Effects: Some common side effects include nausea, headache, fatigue, and gastrointestinal discomfort such as diarrhea.
  • Serious Side Effects: Although rare, serious side effects can include severe allergic reactions, liver dysfunction, and skin reactions. Immediate medical attention is required if these symptoms occur.
  • Monitoring: Regular monitoring of liver function and overall health is recommended to detect any adverse effects early.

Precautions

  • Medical History: Inform your doctor of any medical history, particularly liver disease, kidney issues, or allergies.
  • Pregnancy and Breastfeeding: EPSTATE SR 150 should be used during pregnancy only if clearly needed and prescribed by your doctor. Consult your doctor before breastfeeding.
  • Interactions: Provide a list of all medications, supplements, and herbal products you are taking to avoid potential interactions.

Conclusion

Epalrestat Tablets ER (50mg), known as EPSTATE SR 150, is an effective medication for managing diabetic neuropathy. By inhibiting the enzyme aldose reductase, it helps reduce nerve pain and other related symptoms. Following the prescribed dosage and maintaining regular monitoring can significantly improve the quality of life for diabetic patients. Always consult with your healthcare provider for personalized advice and report any unusual symptoms promptly.Steris Healthcare Pvt Ltd, founded by a group of expert professionals in the pharmaceutical industry in February 2018, operates as Sterispharma. This company, which is based in Navi Mumbai, holds certifications from WHO, GMP, and ISO. Its commitment is to provide high-quality drugs at affordable prices to its customers throughout India, following the rigorous guidelines set by the WHO. Steris offers the convenience of an online pharmacy where customers can easily buy medicines and enjoy the benefit of home delivery. At Steris, the mission is to supply a wide array of healthcare products designed to meet the varied needs of the medical community. Whether it is advanced treatments, medications for rare conditions, or basic health necessities, Sterispharma strives to serve the healthcare industry’s broad demands. The extensive product lineup from Steris includes treatments for various health areas such as Cardiology, Asthma, Respiratory issues, Nasal conditions, Diabetes, Endocrinology, Gastroenterology, Orthopedics, Anti-infectives/antibiotics, General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental care, and Dermatology.

  For further information: 

 

 EMAIL:  info@sterispharma.com  / contact@sterispharma.com   

 CALL/WHATSAPP: 7877551268, 7849827488

 

   BUY NOW

 

SHARE WITH